No significant link found between biologics, melanoma development in inflammatory diseases

Patients treated with biologic therapy for inflammatory diseases may not have a higher risk for developing melanoma, a systematic review and meta-analysis found.Seven cohort studies, including more than 34,000 patients treated with biologics and more than 135,000 patients treated with systemic therapies, were analyzed in the review. Two studies involved patients with inflammatory bowel disease, four studies involved patients with rheumatoid arthritis, and one study involved patients with psoriasis.The pooled relative risk for melanoma in patients with IBD treated with biologics compared withRead More

Share on facebook
Share on twitter
Share on linkedin